VLS
VLSCIENCE FPO [VLS]
Healthcare · ASX Small Cap
$2.6900 +0.8%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 3 consecutive scans→ Score +0First seen: 2026-02-25
Score Breakdown
Technical81
Catalyst50
Sentiment50
Fundamental94
Momentum75
Risk Gate47
Active Signals
Bullish Signals
- MACD bullish crossover
- Sustained volume spike (12.3x median) on UP trend
- Volatility contracting (breakout setup)
- Above 200-day MA (long-term uptrend)
- Cash positive / operating cashflow positive
- Low P/S ratio (1.6x)
- Moderate revenue growth (+19%)
- Piotroski F-Score strong (9/9)
- CANSLIM C: Positive EPS growth (25% QoQ)
- CANSLIM N: Near 52-week high (breakout territory)
- CANSLIM S: Tight float (37%)
- Strong return on equity (19%)
- Positive 12-1 momentum (+44%)
- Excellent risk-adjusted momentum (Sharpe 1.6)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Update - Notification of buy-back - VLS
NONE Update - Notification of buy-back - VLS
NONE Update - Notification of buy-back - VLS
Recent ASX Announcements
| 2026-02-26 | Update - Notification of buy-back - VLS |
| 2026-02-25 | Update - Notification of buy-back - VLS |
| 2026-02-24 | Update - Notification of buy-back - VLS |
| 2026-02-16 | Dividend/Distribution - VLS |
| 2026-02-16 | Preliminary Final Report PRICE SENSITIVE |
Key Metrics
$148.2M
Market Cap
22K
Avg Volume
12.3x
Vol Ratio
$1.70 — $2.84
52-Week Range
N/A
Short Interest
N/A
Cash Runway
19.2%
ROE
11.2%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | weak | EPS Growth: 25% |
| A | Annual Earnings | neutral | CAGR: 2% |
| N | New Highs / Catalysts | pass | Near 52w High |
| S | Supply & Demand | pass | Float: 37% |
| L | Leader vs Laggard | pass | RS: 2 |
| I | Institutional Sponsorship | weak | Inst: 5% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #12 of 119 · Sector avg: 51
View all Healthcare signals →